-
New Drug Therapy Approvals 2019
30 Jan 2023 20:27 GMT
… squamous non-small cell lung cancer, glioblastoma, metastatic renal … squamous non-small cell lung cancer; glioblastoma (cancer originating … : Humira, Rituxan, Enbrel, Herceptin, Avastin, Remicade, and Neulasta … non-small cell lung cancer and locally advanced …
-
Boryung's licensed-in lung cancer drug wins approval in Korea
27 Sep 2022 04:43 GMT
… : lurbinectedin), a small cell lung cancer (SCLC) drug licensed-in … for Zepzelca, a small cell lung cancer (SCLC) drug.
Under … faster than non-small cell lung cancer (NSCLC). SCLC also … and Samfenet, a biosimilar referencing Herceptin, in December.
This year …
-
FDA grants Enhertu accelerated approval for HER2-mutated non-small cell lung cancer
12 Aug 2022 21:21 GMT
… metastatic non-small cell lung cancer.
The approval applies … acid sequence as trastuzumab (Herceptin, Genentech); a topoisomerase … metastatic non-small cell lung cancer (press release). Available … -Metastatic-Non-Small-Cell-Lung-Cancer. Published Aug. 11, …
-
Global Cancer Therapy Market to Surpass US$ 353.5 Billion by 2030, Says Coherent Market Insights (CMI)
24 Jan 2023 14:30 GMT
… metastatic non-small cell lung cancer (NSCLC), as determined … of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase, … cancer
Skin Cancer
Lung Cancer
Others
Global Cancer … Factor), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer …
-
Cancer Monoclonal Antibodies Market Report | Global Analysis, Statistics & Revenue Research Report by 2028
23 Jan 2023 10:00 GMT
…
By Monoclonal Antibody Therapies
• Avastin
• Herceptin
• Keytruda
• Opdivo
• Darzalex
• … • Breast Cancer
• Blood Cancer
• Lung Cancer
• Brain Tumor
• Colorectal Cancer
…
3.2.2. Herceptin
3.2.3. Keytruda … Cancer
3.3.3. Lung Cancer
3.3.4. Brain …
-
Health ministry cuts prices of 20 medicines
17 Jan 2023 02:18 GMT
… include those used to treat lung cancer, breast cancer, HIV, blood clotting … to treat non-small cell lung cancer and pancreatic cancer, has been … ,320.
The price of 450mg Herceptin injection, administered to treat types …
-
New Drug Therapy Approvals 2022
10 Jan 2023 17:17 GMT
… with known or suspected lung cancer.
Dupixent (dupilumab) injection … non-small cell lung cancer with no sensitizing … -approved treatment for neoadjuvant lung cancer.
Opzelura (ruxolitinib) cream … Neulasta; five biosimilars to Herceptin; four biosimilars to …
-
Anti-Cancer Drug Market is expected to grow from USD 150.6 billion in 2022 to USD 266.5 billion by 2030 : GreyViews
03 Jan 2023 16:00 GMT
… .
Segmentation Analysis The lung cancer segment is expected to … segment is breast cancer, lung cancer, prostate cancer, gynecologic cancer … , and others. The lung cancer segment is expected to witness … this gene is trastuzumab (Herceptin), which is approved to …
-
Zymeworks Inc. (NYSE:ZYME) Q3 2022 Earnings Call Transcript
30 Dec 2022 05:19 GMT
… cancer, non-small cell lung cancer, ampullary cancer, endometrial cancer … of non-small cell lung cancer, which has three distinct … in non-small cell lung cancer patients we plan to … previously conducted looking at Herceptin, Abemaciclib and fulvestrant. Thanks …
-
The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering
06 Dec 2018 13:14 GMT
… for advanced non-small cell lung cancer. The decision follows recommendation … by 50 percent compared to Herceptin, thus meeting the primary … to 77.0% treated with Herceptin, an 11.3% improvement … (OTC: RHHBY)'s Herceptin, being evaluated for single hormone …